Xinjiang Xinqikang Pharmaceutical

Xinjiang Xinqikang Pharmaceutical is a prominent Chinese pharmaceutical company dedicated to the modernization and industrialization of ethnic medicines, specifically Uighur and Traditional Chinese Medicine (TCM). Headquartered in Urumqi, the company focuses on therapeutic areas including respiratory health, gynecology, pediatrics, and orthopedics. Its flagship product, Zukamu Granules, is a widely recognized treatment for the common cold and flu in China. Xinjiang Xinqikang integrates research, cultivation of medicinal herbs, and GMP-certified manufacturing to provide a diverse portfolio of proprietary herbal drugs. The company is a key enterprise in the Xinjiang region and actively explores international markets in Central Asia. It is listed on the National Equities Exchange and Quotations (NEEQ) and is recognized as a national high-tech enterprise.